Paydas, S. Et Al. 2018. EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .

Paydas, S., Mirili, C., Bagir, E., Seydaoglu, G., Ogul, A., Buyuksimsek, M., ... Yetisir, A. E.(2018). EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

Paydas, SEMRA Et Al. "EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

Paydas, SEMRA Et Al. "EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

Paydas, S. Et Al. (2018) . "EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

@article{article, author={SEMRA PAYDAŞ Et Al. }, title={EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}